Official Journal of the European Behavioural Pharmacology Society (EBPS)

Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:

Human Psychopharmacology: Experimental

This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.

Human Psychopharmacology: Clinical and Translational

This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.

Preclinical psychopharmacology: Behavioral and Neural

This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.

Preclinical Psychopharmacology: Translational

This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.

Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic

This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.

The journal welcomes submissions in all of these fields.

Details Concerning the Submission and Publication Procedures:
- No Page Charges
- No Fees for Online Color Images
- Optional Color Images in Print – EUR 950/USD 1150. VAT or local taxes will be added where applicable.
- Optional Open Access Publication Fee (APC) - EUR 2990/USD 3760/GBP 2490. VAT or local taxes will be added where applicable.

  • Publishes research and reviews of mechanisms by which drugs affect behavior
  • Extends from clinical psychopharmacology to studies of effects of drugs on human cognition and behavior
  • Covers methodologies from neurochemical assays to functional neuroimaging studies

Journal information

Coordinating Editor
  • Trevor W. Robbins,
  • Christelle Baunez,
  • Patricia H. Janak
Principal Editor
  • Harriet de Wit,
  • Valerie H Curran,
  • A. Leslie Morrow,
  • Kenji Hashimoto,
  • Oliver Howes,
  • Stan B. Floresco,
  • Deepak D'Souza
Publishing model
Hybrid. Learn about publishing OA with us

Journal metrics

3.130 (2019)
Impact factor
3.179 (2019)
Five year impact factor
59 days
Submission to first decision
168 days
Submission to acceptance
1,161,507 (2019)
Downloads

Latest articles

Journal updates

  • COVID-19 and impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

  • Call for papers for a Special issue on “Cannabis and Cannabinoids”

    Psychopharmacology is pleased to announce that the Editors Deepak Cyril D’Souza and Val Curran are putting together a Special Issue on “Cannabis and Cannabinoids”.  Relevant submissions are invited from preclinical and clinical researchers in this field.  Our deadline for submission will be December 20th, 2020.

  • Call for Papers for a Special Issue on "Nature vs Nurture in Addiction Research"

    Guest Editor: Charles Bradberry

    The genesis of the topic was a session at the European Behavioral Pharmacology Society meeting in Portugal in 2019 focused on longitudinal imaging in animals and humans exposed to psychostimulants, but this issue also welcomes articles or reviews on any drug of abuse, including ethanol. Papers should address either issues of vulnerability, or chronic effects that inform cross-sectional clinical comparisons.

    Our deadline for submission will be Nov. 1, 2020, with an anticipated publication date of summer 2021.

View all updates

Subscribe

eJournal
$199.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access with complete access to all articles
  • Downloadable in PDF format
  • Subscription expires 12/31/2020

About this journal

Electronic ISSN
1432-2072
Print ISSN
0033-3158
Abstracted and indexed in
  1. BIOSIS
  2. Biological Abstracts
  3. CAB Abstracts
  4. CNKI
  5. Chemical Abstracts Service (CAS)
  6. Current Contents/ Life Sciences
  7. Dimensions
  8. EBSCO Academic Search
  9. EBSCO Advanced Placement Source
  10. EBSCO Biomedical Reference Collection
  11. EBSCO CINAHL
  12. EBSCO Discovery Service
  13. EBSCO Psychology & Behavioral Sciences Collection
  14. EBSCO Rehabilitation & Sports Medicine Source
  15. EBSCO SPORTDiscus
  16. EBSCO STM Source
  17. EMBASE
  18. ERIH PLUS
  19. Gale
  20. Google Scholar
  21. Highbeam
  22. IFIS Publishing
  23. Institute of Scientific and Technical Information of China
  24. Japanese Science and Technology Agency (JST)
  25. Journal Citation Reports/Science Edition
  26. Medline
  27. Meta
  28. Naver
  29. OCLC WorldCat Discovery Service
  30. Pathway Studio
  31. ProQuest Agricultural & Environmental Science Database
  32. ProQuest Animal Behavior Abstracts
  33. ProQuest Biological Science Database
  34. ProQuest Central
  35. ProQuest Chemoreception Abstracts
  36. ProQuest Environmental Science
  37. ProQuest Health & Medical Collection
  38. ProQuest Health Research Premium Collection
  39. ProQuest Medical Database
  40. ProQuest Natural Science Collection
  41. ProQuest Neurosciences Abstracts
  42. ProQuest Nursing & Allied Health Database
  43. ProQuest Pharma Collection
  44. ProQuest Psychology Database
  45. ProQuest SciTech Premium Collection
  46. ProQuest Toxicology Abstracts
  47. ProQuest-ExLibris Primo
  48. ProQuest-ExLibris Summon
  49. PsycINFO
  50. Qinsight
  51. Reaxys
  52. SCImago
  53. SCOPUS
  54. Science Citation Index
  55. Science Citation Index Expanded (SciSearch)
  56. TD Net Discovery Service
  57. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer-Verlag GmbH Germany, part of Springer Nature